On March 5, 2026, the FDA published its final rule standardizing all National Drug Codes to a uniform 12-digit format using a 6-4-2 structure. This post breaks down what the ruling says, what the timeline looks like, how existing NDC-11 values convert to NDC-12, and what this means for GTINs, GS1 barcodes, and the broader pharmaceutical supply chain. If you work in pharmacy, supply chain, or healthcare IT, this is the change you need to start planning for.
Understanding the packaging indicator in a GTIN-14 is essential for distinguishing pharmaceutical products across different packaging levels. From single-dose units to master cases, this leading digit encodes a product’s position in the packaging hierarchy—without changing its identity. Correct usage ensures seamless serialization, barcode accuracy, and DSCSA compliance. Whether labeling a vial or pallet, assigning the right packaging indicator is a small step with big implications for traceability and supply chain integrity.
Explains how to accurately convert a 10-digit National Drug Code (NDC-10) to a GTIN-14 identifier for use in GS1-compliant barcodes. The GTIN-14 is constructed by combining a packaging indicator, the fixed GS1 pharmaceutical prefix “03”, the raw NDC-10, and a Modulo 10 check digit. This post details the correct 14-digit structure, provides a step-by-step check digit calculation, and includes Python code to automate the process. This guidance is essential for pharmaceutical serialization, traceability, and DSCSA compliance.
As the U.S. drug supply chain grows more automated, the FDA is proposing a shift from the current 10- and 11-digit National Drug Code (NDC) formats to a standardized 12-digit structure. This change is driven by the looming exhaustion of 5-digit labeler codes and aims to enhance clarity, automation, and long-term sustainability. NDC 12 adopts a fixed 6-4-2 segment format, enabling better compatibility with GS1 standards, improved barcode readability, and seamless integration with traceability systems. The transition, expected to begin in 2025, will impact barcoding, GTINs, and data processing systems-requiring healthcare organizations to start preparing now.
As pharmaceutical supply chains shift toward unit-level traceability under regulations like DSCSA and the FMD, the structure of RFID-encoded drug data is becoming crucial. This post explains how GS1’s EPC encoding formats—SGTIN-96, SGTIN-96+, and SGTIN-198—impact drug serialization and compliance. While SGTIN-96 requires external databases, SGTIN-96+ adds expiration and lot number data to user memory for offline verification. However, EPC 2.x’s SGTIN-198 format fully embeds all critical data within the tag itself, offering the most standardized, compliant, and future-ready solution. For long-term interoperability and regulatory alignment, EPC 2.x is the recommended path forward.